← SynDRA
BMS-986094
SynDRA canonical compound SYN0655800 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | antiviral |
All known targets
Mechanisms of action (all sources)
Drug classes
Cross-references
Synonyms
- RefChem:359721
- SCHEMBL17613004
- PD132648
- NS00072782
- SCHEMBL14934184
- DA-61764
- CS-0003198
- INX-089
- SCHEMBL14934186
- GLXC-07661
- UNII-62F4AD749Y
- EX-A14456
- INX-08189
- INX-08189 2,2-DIMETHYLPROPYL ESTER
- MFCD22124897
- AKOS040748584
- orb1700336
- MFCD31803955
- INX-189
- Nucleoside polymerase inhibitors (oral, HCV infection), Inhibitex
- DTXCID4076508
- BMS 986094 [WHO-DD]
- INX08189
- INX-108
- C30H39N6O9P
- INX 08189
- AKOS037647691
- Nucleoside polymerase inhibitors (HCV infection), Cardiff University/Rega Institute
- RefChem:926599
- HY-13337
- INX-08032
- BMS 986094
- SCHEMBL31554843
- SCHEMBL29399332
- AS-74509
- SCHEMBL15628174
Look up BMS-986094 in the interactive SynDRA portal →